NEW YORK, April 20 - Canadian population genetics company Xenon Genetics has kept a low profile since its founding four years ago, but since Xenon raised $45 million earlier this month in a private placement, despite current market conditions, some in the genomics community have begun to sit up and take notice.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.